Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Automated Vial Capper Machine and Labeler system

Closed
75F40126Q133944Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The solicitation for an Automated Vial Capper and Labeler system, issued under solicitation number 75F40126Q133944 by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, is a total small business set-aside under NAICS code 333993, with a size standard of 600 employees. The procurement is conducted on a lowest price technically acceptable (LPTA) basis, where technical acceptability serves as the sole pass/fail threshold before price is evaluated. The system must be newly manufactured, turn-key, and capable of capping 13mm and 20mm aluminum crimp caps on 3mL and 5mL vials at a minimum rate of 60 vials per minute, with integrated labeling that supports two specific label sizes without barcode requirements. Delivery and installation are to occur at the FDA’s Silver Spring, Maryland facility, with all work subject to stringent security protocols requiring contractor personnel to have valid government-issued identification, be escorted at all times, and comply with parking and access procedures. The system must include installation, installation qualification, operational qualification, performance qualification, and comprehensive on-site training, with a mandatory 12-month warranty covering parts, labor, travel, and preventive maintenance. The contract requires full compliance with Section 508 accessibility standards, necessitating submission of an Accessibility Conformance Report or HHS Section 508 checklist, and adherence to the Buy American Act. All invoice submissions must be electronically filed through the Treasury’s Invoice Processing Platform, with no alternative methods permitted without prior written approval. Contract performance is governed by strict delivery timelines: equipment must be delivered within 196 calendar days of award, with installation and qualification completed by day 226, and an optional three-year post-warranty service agreement is available for annual preventive maintenance and unlimited corrective support. The contractor is responsible for onsite unpacking, visual inspection for damage, and must provide complete operation and maintenance manuals in printed and electronic formats. No shipping charges are allowed, and all deliveries must occur between 9:00 AM and 3:00 PM with 48-hour advance notice. The contracting officer is Nick Sartain, and offers must be submitted via email by 1:00 p.m. Central Time on July 31, 2026. The solicitation includes deviations from standard FAR clauses across multiple areas including commercial item terms

General Info

FDA seeks small business to supply vial capper and labeler system by July 27, 2026, in Silver Spring, Maryland.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

333993 - Packaging Machinery ManufacturingView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

SBA

Documents

(4)

Solicitation 75F40126Q133944 Automated Vial Capper and Labeler RFQ

PDFrfq

Solicitation 75F40126Q133944 Automated Vial Capper and Labeler RFQ

PDFrfq

Questions and Answers Amendment 1 for Vial Capping and Labeling SOW

DOCXq-and-a

Questions and Answers for Automated Vial Capper and Labeler System

DOCXq-and-a

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseClosed
Posted

Combined Synopsis

Amendment 1

Contract was updated

Amendment 2

Contract was updated

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA

Full Description

Show more

7/22/2026: Questions and answers is attached. 


07/21/2026 — Solicitation Amendment 1 has been posted along with the responses to questions received. Any remaining questions must be submitted no later than 4:00 PM Central Time today, July 21, 2026.


See attached combined synopsis/solicitation.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS